Loading...

Kaneka Corporation

KANKFPNK
Basic Materials
Chemicals - Specialty
$24.90
$0.00(0.00%)

Kaneka Corporation (KANKF) Financial Performance & Income Statement Overview

Access detailed quarterly and annual financial reports for Kaneka Corporation (KANKF), covering cash flow, earnings, and balance sheets.

Revenue Growth
0.86%
0.86%
Operating Income Growth
-7.15%
7.15%
Net Income Growth
0.92%
0.92%
Operating Cash Flow Growth
115.64%
115.64%
Operating Margin
4.96%
4.96%
Gross Margin
27.95%
27.95%
Net Profit Margin
3.14%
3.14%
ROE
5.47%
5.47%
ROIC
6.41%
6.41%

Kaneka Corporation (KANKF) Income Statement & Financial Overview

Explore comprehensive income reports for Kaneka Corporation KANKF, broken down by year and quarter.

MetricQ4 2025Q3 2025Q2 2025Q1 2025
Revenue$204.15B$207.09B$197.58B$198.38B
Cost of Revenue$146.64B$150.06B$142.92B$142.95B
Gross Profit$57.51B$57.02B$54.66B$55.44B
Gross Profit Ratio$0.28$0.28$0.28$0.28
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$47.61B$46.99B$45.84B$45.16B
Operating Expenses$47.61B$46.99B$45.83B$45.16B
Total Costs & Expenses$194.25B$197.05B$188.76B$188.11B
Interest Income$295.00M$0.00$0.00$0.00
Interest Expense$1.02B$0.00$1.05B$1.02B
Depreciation & Amortization$10.85B$10.19B$10.71B$10.19B
EBITDA$14.52B$20.23B$19.53B$20.47B
EBITDA Ratio$0.07$0.10$0.10$0.10
Operating Income$9.90B$10.03B$8.82B$10.28B
Operating Income Ratio$0.05$0.05$0.04$0.05
Other Income/Expenses (Net)-$950.00M$2.15B-$3.33B-$131.00M
Income Before Tax$8.95B$12.18B$5.49B$10.14B
Income Before Tax Ratio$0.04$0.06$0.03$0.05
Income Tax Expense$1.07B$4.17B$1.99B$2.73B
Net Income$7.57B$7.58B$3.13B$7.03B
Net Income Ratio$0.04$0.04$0.02$0.04
EPS$120.33$119.98$49.57$110.36
Diluted EPS$119.94$120.35$49.57$110.04
Weighted Avg Shares Outstanding$63.14M$63.13M$63.12M$63.73M
Weighted Avg Shares Outstanding (Diluted)$63.15M$62.93M$63.12M$63.91M

Over the past four quarters, Kaneka Corporation demonstrated steady revenue growth, increasing from $198.38B in Q1 2025 to $204.15B in Q4 2025. Operating income reached $9.90B in Q4 2025, maintaining a consistent 5% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $14.52B, reflecting operational efficiency. Net income dropped to $7.57B, with EPS at $120.33. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;